Tabrecta Indications/Uses

capmatinib

Manufacturer:

Novartis

Distributor:

Zuellig Pharma

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Thai FDA Category Presentation/Packing Local Product Insert

Full Prescribing Info

Indications/Uses

Tabrecta is indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) with a MET exon 14 skipping mutation (see Pharmacology: Pharmacodynamics under Actions).

Asia's one-stop resource for medical news, clinical reference and education

Already a member? Sign in

Asia's one-stop resource for medical news, clinical reference and education

Already a member? Sign in